New Brunswick Scientific Retains Clear Perspective Group to Expand and Enhance Investor Awareness
10 Juin 2004 - 2:05PM
PR Newswire (US)
New Brunswick Scientific Retains Clear Perspective Group to Expand
and Enhance Investor Awareness EDISON, N.J., June 10
/PRNewswire-FirstCall/ -- New Brunswick Scientific Co., Inc.
(NASDAQ:NBSC) ("NBS") today announced that it has retained Clear
Perspective Group, LLC ("CPG") as its investor relations counsel to
broaden the company's reach and improve visibility within the
investment community. Commenting on the move, New Brunswick
Scientific Chairman David Freedman stated: "After a capital
spending slowdown in 2003, the life science industry has
experienced a broad-based rebound in recent months. Improving
market conditions appear to be sustainable, boding well for the
balance of this year and beyond. Consequently, we feel it is
appropriate to expand our investor relations initiatives and
increase our visibility in the financial community." Matthew
Dennis, CFA, senior managing director of Clear Perspective Group,
said: "New Brunswick Scientific fits extremely well with CPG's
capabilities. We feel the company's investment merits are very
impressive yet lack notoriety among investors. NBS' proprietary
technology and products are world class and considered the vanguard
in an improving industry. Not many investors outside of the biotech
arena are aware that NBS' proprietary CelliGen Plus(R) packed- bed
perfusion bioreactor was chosen for the production of the world's
first commercially licensed gene therapy drug. "While the company's
brands are highly respected and sought-after in the life science
community, the branding of the company's stock can be noticeably
improved," he added. "CPG will expand the company's investor
following by making it easier for investors to understand and
follow company developments, concisely articulating NBS' investment
merits, and introducing management to targeted centers of influence
in the capital markets, including institutional portfolio managers,
buy- and sell-side equity analysts, brokers, and financial media.
"NBS has been producing state-of-the-art equipment for more than 50
years. These products are critical to success in the biotechnology,
pharmaceutical, and research industries. With the company's recent
complementary acquisition of RS Biotech, it offers the essential
elements found in a comprehensive industry laboratory: biological
shakers, ultra-low temperature freezers, and now carbon dioxide
incubators." Dennis continued: "From a fundamental investment
standpoint, we think NBS is very attractive. Sales increased more
than 26 percent in this year's first quarter versus the prior-year
period, gross margins have been above 40 percent for the two most
recent quarters, and the balance sheet is very sound. The debt to
equity ratio is less than 30 percent and the company creates
substantial free cash flow. Cash and equivalents have increased in
each of the past four years and the company currently has more than
one dollar per share in cash." Freedman concluded: "We selected CPG
due to its strong relationship focus, contacts in the financial
community, and its experienced personnel. The organization has
constructed unique technology platforms, which we anticipate will
not only increase the awareness of our stock, but also enable us to
redirect in-house resources to other areas of the business while
reducing certain recurring costs associated with being a public
company." To be added to the company's e-mail distribution list,
please click on the link below:
http://www.b2i.us/frame.asp?BzID=941&to=ea&Nav=1&S=0&L=1
About New Brunswick Scientific New Brunswick Scientific Co., Inc.
(NASDAQ:NBSC) (NBS) is a leading global provider of a comprehensive
line of research equipment and scientific instrumentation for use
in the life science industry. The company's products are used in
the creation, maintenance, and control of physical and biochemical
environments required for the growth, detection, and storage of
microorganisms for medical, biological, and chemical applications,
as well as environmental research and commercial product
development. NBS is a forerunner in the research and development of
pioneering equipment to meet the challenges of new areas of
advancement in the life sciences. Established in 1946, New
Brunswick Scientific is headquartered in Edison, New Jersey, with
sales and distribution facilities strategically located in the
United States, Europe, and Asia. For more information, please
visit: http://www.nbsc.com/ . About Clear Perspective Group A
full-service investor relations consulting firm, Clear Perspective
Group, LLC (CPG)(SM), benefits clients via its dedication to
cultivating long- lasting relationships while setting industry
standards for effective service and cost minimization. More than
six decades of collective experience enable CPG's managing
directors to identify and clearly communicate a company's
investment merits so that the market accurately realizes the
intrinsic value of its securities. In addition to enhancing a
company's image within the financial community as it increases
exposure to investors, CPG's vast assemblage of resources and
state-of-the-art technology alleviate many of the time burdens and
recurrent costs associated with public ownership. For more
information, please visit: http://www.cpg-llc.com/ . This press
release includes statements that may constitute forward-looking
statements made pursuant to the Safe Harbor provision of the
Private Securities Litigation Reform Act of 1995. This information
may involve risks and uncertainties that could cause actual results
to differ materially from the forward-looking statements. Although
the Company believes that the expectations reflected in such
forward-looking statements are based on reasonable assumptions,
such statements are subject to risks and uncertainties that could
cause actual results to differ materially from those projected.
Further information concerning risk factors is described in the
Company's Securities and Exchange Commission filings. DATASOURCE:
New Brunswick Scientific Co., Inc. CONTACT: Investors, Samuel
Eichenbaum, Vice President, Finance and Treasurer, New Brunswick
Scientific Co., Inc., +1-732-650-2500, ; or Matthew J. Dennis, CFA,
NBS Investor Relations, Clear Perspective Group, LLC,
+1-440-353-0552, Web site: http://www.nbsc.com/
http://www.cpg-llc.com/
Copyright
New Brunswick Scientific (NASDAQ:NBSC)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
New Brunswick Scientific (NASDAQ:NBSC)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024